These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10068648)

  • 1. Induction of fetal hemoglobin in sickle cell disease.
    Bunn HF
    Blood; 1999 Mar; 93(6):1787-9. PubMed ID: 10068648
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ; Charache S
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing ontogeny.
    Bunn HF
    N Engl J Med; 1993 Jan; 328(2):129-31. PubMed ID: 7677964
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
    Atweh GF; Schechter AN
    Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
    Atweh GF; Sutton M; Nassif I; Boosalis V; Dover GJ; Wallenstein S; Wright E; McMahon L; Stamatoyannopoulos G; Faller DV; Perrine SP
    Blood; 1999 Mar; 93(6):1790-7. PubMed ID: 10068649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapatient variability in fetal hemoglobin measurements over time in sickle cell patients not on fetal hemoglobin inducing agents.
    Knapp E; Cohen H; Kutlar A; Ghalie R; Manwani D
    Am J Hematol; 2016 Mar; 91(3):E11-2. PubMed ID: 26661045
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract]   [Full Text] [Related]  

  • 8. The biophysics of sickle cell hydroxyurea therapy.
    Eaton WA; Hofrichter J
    Science; 1995 May; 268(5214):1142-3. PubMed ID: 7539154
    [No Abstract]   [Full Text] [Related]  

  • 9. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
    Kutlar A; Reid ME; Inati A; Taher AT; Abboud MR; El-Beshlawy A; Buchanan GR; Smith H; Ataga KI; Perrine SP; Ghalie RG
    Am J Hematol; 2013 Nov; 88(11):E255-60. PubMed ID: 23828223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease.
    Saleh AW; Hillen HF
    Neth J Med; 1997 Nov; 51(5):169-78. PubMed ID: 9455096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of fetal hemoglobin in the treatment of sickle cell disease.
    Fathallah H; Atweh GF
    Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM; Pace B
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH
    Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS
    Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapeutic reactivation of fetal haemoglobin.
    Olivieri NF; Weatherall DJ
    Hum Mol Genet; 1998; 7(10):1655-8. PubMed ID: 9735388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.